Program
Varenicline
Also written as “varenicline”, “Varenicline Tartrate” and “varenicline (CP-526,555)”.
Its studies are mostly in Smoking Cessation · Dry Eye Syndromes · Smoking · Trigeminal Neuralgia · Cigarette Smoking, led by 6 companies.
Drug pageVarenicline: every studyMany companies study it; this page follows only the 44 they lead. All 254 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pfizer | 320 open or running | phase 4since Jan 3, 2008 | Aug 29, 2005 | none ahead |
| Viatrisits history only | 60 open or running | phase 3since Jul 25, 2019 | Aug 15, 2018 | none ahead |
| Corxel Pharmaceuticalsits history only | 20 open or running | phase 3since May 13, 2022 | May 13, 2022 | none ahead |
| Rose Research Centerits history only | 20 open or running | phase 4since Jun 6, 2019 | Jun 6, 2019 | none ahead |
| Kriya Therapeuticsits history only | 11 open or running | phase 2since Apr 17, 2026 | Apr 17, 2026 | Feb 2029phase 2 · NCT07596485 |
| SRI Internationalits history only | 10 open or running | no phasesince Mar 8, 2006 | Mar 8, 2006 | none ahead |
Also a collaborator on its studies: GlaxoSmithKline.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Pfizer only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 17 studies since Aug 29, 2005.
- Mar 21, 2008Phase 3 study in Smoking CessationNCT00644969 · 128 enrolled · United States, Canada
- Apr 14, 2008Phase 1 study in Smoking CessationNCT00661765 · 18 enrolled · United States
- Jun 3, 2008Phase 4 study in Smoking CessationNCT00691483 · 659 enrolled · United States, Argentina, Brazil and more
- Jun 5, 2008Phase 1 study in HealthyNCT00694044 · 50 enrolled · United States
- Jul 15, 2008Phase 4 study in Tobacco Use CessationNCT00717093 · 432 enrolled · Norway, Sweden
- Aug 27, 20082 phase 2 studiesNCT00743847, NCT00744978
- Sep 9, 2008Phase 4 study in Smoking CessationNCT00749944 · 110 enrolled · United States
- Apr 28, 2009Phase 4 study in Smoking CessationNCT00889720 · 16 enrolled · France, Italy
- Feb 26, 2010Phase 4 study in Smoking CessationNCT01078298 · 525 enrolled · United States, Bosnia and Herzegovina, Croatia and more
- Nov 17, 2010Phase 4 study in Smoking CessationNCT01244061 · 498 enrolled · United States, Australia, Belgium and more
- Mar 9, 2011Phase 4 study in Smoking CessationNCT01312909 · 312 enrolled · United States, Canada, Georgia and more
- Jun 8, 2011Phase 4 study in Smoking CessationNCT01370356 · 1,510 enrolled · United States, Australia, Canada and more
- Oct 14, 2011Phase 4 study in Smoking CessationNCT01456936 · 8,144 enrolled · United States, Argentina, Australia and more
- Apr 6, 2012Phase 4 study in Smoking CessationNCT01574703 · 4,595 enrolled · United States, Argentina, Australia and more
TargetBeta
“Neuronal acetylcholine receptor; alpha4/beta2 agonist; Neuronal acetylcholine receptor; alpha4/beta2 partial agonist”ChEMBL 37, by rule
Other programs on the same two targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| cytisinerule | Achieve Life Sciences | phase 3 | 13 |
Studies
All 32 Pfizer leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01574703Smoking Cessation · United States, Argentina, Australia and more | 4 | Completed | Jul 2015 | 4,595 |
| NCT01456936Smoking Cessation · United States, Argentina, Australia and more | 4 | Completed | Jan 2015 | 8,144 |
| NCT01370356Smoking Cessation · United States, Australia, Canada and more | 4 | Completed | Jul 2013 | 1,510 |
| NCT01312909Smoking Cessation · United States, Canada, Georgia and more | 4 | Completed | Jan 2018 | 312 |
| NCT01244061Smoking Cessation · United States, Australia, Belgium and more | 4 | Completed | Nov 2012 | 498 |
| NCT01078298Smoking Cessation · United States, Bosnia and Herzegovina, Croatia and more | 4 | Completed | Jun 2012 | 525 |
| NCT00889720Smoking Cessation · France, Italy | 4 | Completed | Jul 2010 | 16 |
| NCT00749944Smoking Cessation · United States | 4 | Completed | Jul 2009 | 110 |
| NCT00744978Alzheimer Disease · Korea, Republic of | 2 | Completed | Nov 2010 | 66 |
| NCT00743847Schizophrenia | 2 | Withdrawn | Nov 2009 | 0 |
| NCT00717093Tobacco Use Cessation · Norway, Sweden | 4 | Completed | Apr 2009 | 432 |
| NCT00694044Healthy · United States | 1 | Completed | Jun 2008 | 50 |
| NCT00691483Smoking Cessation · United States, Argentina, Brazil and more | 4 | Completed | Sep 2009 | 659 |
| NCT00661765Smoking Cessation · United States | 1 | Completed | Jun 2008 | 18 |
| NCT00644969Smoking Cessation · United States, Canada | 3 | Completed | Apr 2010 | 128 |
| NCT00635401Smoking · Japan | 2 | Completed | 30 | |
| NCT00594204Smoking Cessation · Brazil, Colombia, Costa Rica and more | 4 | Completed | Jun 2009 | 593 |
| NCT00527150Smoking Cessation · United States | 1 | Completed | Feb 2008 | 48 |
| NCT00463918Smoking Cessation · United States, United Kingdom | 1 | Completed | 73 | |
| NCT00452894Smoking · China | 1 | Completed | 14 | |
| NCT00371813Smoking Cessation · China, Singapore, Thailand | 3 | Completed | 334 | |
| NCT00282984Smoking Cessation · United States, Argentina, Australia and more | 3 | Completed | Nov 2007 | 714 |
| NCT00150254Smoking Cessation · United States | 2 | Completed | 625 | |
| NCT00150241Smoking Cessation · United States | 2 | Completed | 625 | |
| NCT00150228Smoking Cessation · United States | 2 | Completed | 300 | |
| NCT00143364Smoking Cessation · United States | 3 | Completed | 1,005 | |
| NCT00143325Smoking Cessation · United States, Belgium, France and more | 3 | Completed | 730 | |
| NCT00143299Smoking Cessation · United States, Australia | 3 | Completed | 375 | |
| NCT00143286Smoking Cessation · United States, Canada, Czech Republic and more | 3 | Completed | 2,000 | |
| NCT00141206Smoking Cessation · United States | 3 | Completed | 1,005 | |
| NCT00141167Smoking Cessation · Korea, Republic of, Taiwan | 3 | Completed | 250 | |
| NCT00139750Smoking Cessation · Japan | 2 | Completed | 600 |
How it is read
Names in the registry
- “varenicline”, 11 entries
- “Varenicline Tartrate”, 7 entries
- “Varenicline”, 6 entries
- “varenicline (CP-526,555)”, 6 entries
- “CP-526,555 (varenicline)”, 4 entries
Conditions, from the studies’ own filings
- Smoking Cessation, 28 studies
- Dry Eye Syndromes, 6 studies
- Smoking, 2 studies
- Trigeminal Neuralgia, 1 study
- Cigarette Smoking, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.